The Recall Desk

Manufacturer

Synthetopes Inc

8 recalls in our database name Synthetopes Inc as the manufacturing or recalling firm.

What the numbers show

Total
8
Critical
0
Severe
2
Most recent
2019-06-19

Of the 8 recalls from Synthetopes Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (25%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–8 of 8

  • SevereFDA (Drugs)·D-1403-2019·2019-06-19

    Synthetopes Recalls Sn-d, l-Exametazime Due to Lack of Processing Controls

    Synthetopes Inc is recalling Sn-d, l-Exametazime vials nationwide due to a lack of processing controls. The FDA classifies this as a Class II recall.

    Product
    Sn-d, l-Exametazime (Sn-d,l-HMPAO), Not for Direct Injection, Store Below 25 C, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1405-2019·2019-06-19

    Synthetopes Recalls Sn-Tetrofosmin Kits Due to Processing Control Deficiencies

    Synthetopes Inc is recalling Sn-Tetrofosmin Kits nationwide due to a lack of processing controls. All lots remaining within their expiry date are affected.

    Product
    Sn-Tetrofosmin Kit 5.0 mL, Thaw and Vent before use, Not for Direct Injection, Store Frozen, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1404-2019·2019-06-19

    Synthetopes Recalls Sn-DTPA Kit Due to Lack of Processing Controls

    Synthetopes Inc is recalling 82 vials of Sn-DTPA Kit 10 mg nationwide due to a lack of processing controls.

    Product
    Sn-DTPA Kit 10 mg, DTPA, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1401-2019·2019-06-19

    Synthetopes Recalls Sn-Mertiatide Kit Due to Processing Control Deficiencies

    Synthetopes Inc is recalling Sn-Mertiatide Kits nationwide due to a lack of processing controls. The recall covers all lots remaining within their expiry date.

    Product
    Sn-Mertiatide Kit,1 milligram betiatide, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1402-2019·2019-06-19

    Synthetopes Recalls Sulfur Colloid Reaction Vials Due to Processing Controls

    Synthetopes Inc. is recalling Sulfur Colloid Reaction Vials nationwide due to a lack of processing controls.

    Product
    Sulfur Colloid Reaction Vial 1.0 mL, Thaw Before Use, Not for Direct Injection, Store Frozen, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1406-2019·2019-06-19

    Synthetopes Recalls Sn-Pyrophosphate Kits Due to Processing Control Issues

    Synthetopes Inc. is recalling Sn-Pyrophosphate Kits because of a lack of processing controls. The recall covers all lots remaining within their expiry dates.

    Product
    Sn-Pyrophosphate Kit, 11.9 mg sodium pyrophosphate, Not for Direct Injection, Store at Room Temperature, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1399-2019·2019-06-19

    Synthetopes Recalls Pentreotide Vials Due to Lack of Processing Controls

    Synthetopes Inc. is recalling Pentreotide (10 uGm) vials nationwide due to a lack of processing controls. All lots remaining within expiry are affected.

    Product
    Pentreotide (10 uGm), Not for Direct Injection, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1400-2019·2019-06-19

    Synthetopes Recalls Sn-DMSA Solution Due to Processing Control Deficiencies

    Synthetopes Inc. is recalling Sn-DMSA solution vials nationwide due to a lack of processing controls. The product is not for direct injection.

    Product
    Sn-DMSA solution, Store Frozen, Not for Direct Injection, Synthetopes, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide